FDA Approved: VPRIV — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved VPRIV (velaglucerase alfa) from Takeda as the original approval for the treatment of Gaucher disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• VPRIV (VELAGLUCERASE ALFA)

Snippet

ORIG AP for VPRIV (VELAGLUCERASE ALFA)